BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
Allot
ALLT
$383M
| $168K | ﹤0.01% |
16,012
+7,710
| +93% | +$81.7K |
|
4252
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.5B
| $166K | ﹤0.01% |
644
-43
| -6% | -$10.6K |
|
4253
Pulmatrix
PULM
$6.06M
| $166K | ﹤0.01% |
4,817
+3,359
| +230% | +$106K |
|
|
EGPT
4254
DELISTED
VanEck Egypt Index ETF
EGPT
| $165K | ﹤0.01% |
7,037
-1,683
| -19% | -$37.4K |
|
4255
Armata Pharmaceuticals
ARMP
$173M
| $164K | ﹤0.01% |
41,896
+31,842
| +317% | +$110K |
|
4256
iShares Treasury Floating Rate Bond ETF
TFLO
$6.72B
| $164K | ﹤0.01% |
3,263
+305
| +10% | +$15.3K |
|
4257
Gevo
GEVO
$382M
| $162K | ﹤0.01% |
204,517
+6,692
| +3% | +$7.26K |
|
4258
Stellantis
STLA
$20.8B
| $160K | ﹤0.01% |
+15,649
| New | +$135K |
|
|
IMH
4259
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $160K | ﹤0.01% |
95,358
+6,623
| +7% | +$12.2K |
|
4260
Core Molding Technologies
CMT
$234M
| $158K | ﹤0.01% |
38,529
-19,066
| -33% | -$61.4K |
|
4261
Capricor Therapeutics
CAPR
$237M
| $157K | ﹤0.01% |
34,126
+33,523
| +5,559% | +$146K |
|
|
NMTR
4262
DELISTED
9 Meters Biopharma
NMTR
| $156K | ﹤0.01% |
13,599
-4,160
| -23% | -$46.9K |
|
4263
Soligenix
SNGX
$5.81M
| $155K | ﹤0.01% |
306
+249
| +437% | +$103K |
|
4264
Trevi Therapeutics
TRVI
$2.64B
| $155K | ﹤0.01% |
23,713
+14,641
| +161% | +$51.5K |
|
4265
Aterian
ATER
$5.37M
| $154K | ﹤0.01% |
2,330
+1,332
| +133% | +$64.4K |
|
4266
Beam Global
BEEM
$25.3M
| $154K | ﹤0.01% |
15,500
+10,878
| +235% | +$84.6K |
|
|
SMTX
4267
DELISTED
SMTC Corporation
SMTX
| $153K | ﹤0.01% |
50,580
+8,429
| +20% | +$24.7K |
|
4268
First US Bancshares
FUSB
$90.8M
| $152K | ﹤0.01% |
22,049
-662
| -3% | -$4.66K |
|
4269
KNOT Offshore Partners
KNOP
$366M
| $152K | ﹤0.01% |
11,049
-4,606
| -29% | -$63.1K |
|
|
ASXC
4270
DELISTED
Asensus Surgical, Inc.
ASXC
| $152K | ﹤0.01% |
281,224
-906,835
| -76% | -$438K |
|
|
EXFO
4271
DELISTED
EXFO INC.
EXFO
| $151K | ﹤0.01% |
53,537
+22,185
| +71% | +$58.2K |
|
4272
Aehr Test Systems
AEHR
$3.36B
| $150K | ﹤0.01% |
76,604
+11,261
| +17% | +$19.4K |
|
4273
The ONE Group
STKS
$53M
| $149K | ﹤0.01% |
91,398
+10,537
| +13% | +$17.1K |
|
4274
WidePoint Corp
WYY
$114M
| $149K | ﹤0.01% |
21,385
-248
| -1% | -$1.33K |
|
|
ATYR
4275
aTyr Pharma
ATYR
$50.1M
| $148K | ﹤0.01% |
33,463
+24,914
| +291% | +$90.5K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.